Drug Profile
Dexlipotam
Alternative Names: KRX 0701Latest Information Update: 27 Jul 2009
Price :
$50
*
At a glance
- Originator Meda
- Class Carboxylic acids; Eye disorder therapies; Propylene glycols; Small molecules
- Mechanism of Action Oxygen radical formation antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic retinopathy; Type 2 diabetes mellitus
Most Recent Events
- 06 May 2009 Discontinued - Phase-II for Type-2 diabetes mellitus in Germany (PO)
- 05 Sep 2007 This compound is still in active development
- 16 Jun 2004 Preclinical trials in Diabetic retinopathy in Germany (unspecified route)